相关实验视频
Updated: May 27, 2026

06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
33.7K
细胞衰老在肝病中的作用 (综述)
1Department of Hepatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, P.R. China.
International journal of molecular medicine
|September 5, 2025
概括
细胞衰老是衰老的一个关键因素, 针对衰老细胞提供了一种有前途的治疗策略,
科学领域:
- 老年学
- 细胞生物学
- 肝病学
背景情况:
- 细胞衰老是一种不可逆转的细胞循环停止, 是衰老的标志.
- 累积的衰老细胞及其分泌表型 (SASP) 导致组织功能障碍和与年龄相关的疾病.
- 细胞衰老越来越多地被认为是肝脏疾病发病的一个重要因素.
研究的目的:
- 审查肝脏衰老的分子机制和生物标志物.
- 概述细胞衰老在炎症性肝病中的作用.
- 讨论老年治疗作为肝脏疾病的潜在治疗策略.
主要方法:
- 对细胞衰老和肝脏疾病的现有文献进行系统审查.
- 分析与肝脏衰老相关的分子途径和生物标志物.
- 在肝病中对老年治疗药物的临床前和临床证据的评估.
主要成果:
- 细胞衰老与各种肝病的进展有关,与不良的临床结果相关.
- 与衰老相关的分泌表型 (SASP) 导致肝脏炎症和损伤.
- 新兴的老年疗法在向老化细胞和缓解肝炎方面显示出潜力.
结论:
- 细胞衰老在肝脏疾病的发展和进展中起着至关重要的作用.
- 针对细胞衰老和SASP是一个有前途的肝病治疗途径.
- 在肝病患者中,老年治疗药物有改善临床结果的潜力.
相关概念视频
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

